Biodesign and Innovation Seminar Series


Download flyer [here].

DAVID HUNGERFORD, M.D. - Wednesday, April 16

Time: 6:30 pm Location: Johns Hopkins School of Medicine, Pre-Clinical Teaching Building (PCTB), West Lecture Hall. PCTB is Building #20 on the map

Dr. David Hungerford invented the Duracon Total Knee Replacement technology, which has been implanted in approximately 3 million patients. He is currently a Professor in the Department of Orthopaedic Surgery at the Johns Hopkins University. In his talk, entitled "Medical Device Innovation: Total Knee Replacement as a Case Study," Dr. Hungerford will speak about the commercialization path that he pursued and will also provide some pearls of wisdom regarding creativity and device innovation.


HMDN Officer Elections 2008-2009


*NOTE: Application deadline has been extended to April 9 by 11:59 pm

HMDN will be holding its annual officer elections in April. If you are interested in joining a collaborative and motivated team of students, we welcome your application! All applications are due on April 9, 2008 and should be submitted via email to hmdn@jhu.edu.

Download the application [here].

I'm not BME or in engineering, can I still apply?

YES! HMDN seeks to join those with different backgrounds with the aim to promote medical device development.

Are only undergraduates allowed to apply?

Not necessarily. All students are welcome to apply! We have had undergraduates, graduates, and medical students on our board.


Biodesign and Innovation Seminar Series


ROGELIO RODRIGUEZ, M.S. - Tuesday, April 8

Time: 6:00 pm Location: Homewood Campus, Hodson 210

Mr. Rogelio Rodriguez will speak about his experiences in medical device development. He received his B.S. in Engineering from California State University, Fullerton and his M.S. in Engineering from California State University, Long Beach. His master’s thesis was entitled, “Cardiac Bioelectric Activity: Real-Time Simulation of Electrocardiogram.” He currently serves as the Director of Engineering Science Programs at UC Irvine, where his functional role is to address the workforce and the professional development needs of scientific and engineering professionals, and to lead program development for continuing education.

Download the lecture slides [here], the key definitions handout [here], and the case study [here].

FRED BURBANK, M.D. - Thursday, April 3

Time: 5:30 pm Location: Homewood Campus, Computational Science and Engineering Building (CSEB), Room B17

Dr. Fred Burbank, currently the Medical Director of Salt Creek Ventures, has founded three successful medical device companies – Biopsys (acquired by Johnson & Johnson), Vascular Control Systems, and SenoRx. After he received his M.D. from the Stanford School of Medicine, Dr. Burbank completed an internship in Internal Medicine, residencies in Psychiatry and Diagnostic Radiology, and a fellowship in Interventional Radiology. In his talk, he will focus on one company "Vascular Control Systems," and he will discuss the challenges associated with starting a medical device company and with being an entrepreneur, and how his background assisted him along his career path.

MOHIT KAUSHAL, M.D., M.B.A. - Monday, March 31

Time: 5:30 pm Location: Homewood Campus, Clark 110

Dr. Mohit Kaushal is a Venture Associate from the Boston division of Medtronic, where he performs technology scouting duties for the Medicine and Technology group, which is overseen by Dr. Stephen Oesterle. In addition, Dr. Kaushal joined Polaris Venture Partners in September 2007 as a full time employee, where he focuses on investments in the life sciences and spends a significant amount of time concentrating on European health-care opportunities. Prior to obtaining his MBA from the Stanford Graduate School of Business, Dr. Kaushal earned his Medical Degree from the Imperial College of Science, Technology, and Medicine.




Biodesign and Innovation Seminar Series


William Brody - November 29

Time: 6:30 PM Location: Homewood Campus, Charles Common Ballroom

William R. Brody became the 13th president of The Johns Hopkins University on September 1, 1996.  Dr. Brody serves as a trustee of The Commonwealth Fund and of the Baltimore Community Foundation.  He serves on the board of directors of IBM.  He is a member of the executive committee of the Council on Competitiveness, the International Academic Advisory Committee, Singapore, and the FBI's National Security Higher Education Advisory Board.  Dr. Brody is a member of the Institute of Medicine and the National Academy of Engineering, and a fellow of the Institute of Electrical and Electronic Engineers, the American College of Radiology, the American College of Cardiology, the American Heart Association, the International Society of Magnetic Resonance in Medicne, the American Institute of Biomedical Engineering, and the American Academy of Arts and Scieces.

Download flyer [here].


Biodesign and Innovation Seminar Series


Karen Talmadge - October 30

Time: 6:30 PM Location: Homewood Campus, CSE Building, Main Auditorium

IMPORTANT ANNOUNCEMENT: Due to unforeseen circumstances, Dr. Karen Talmadge is rescheduling her lecture, originally scheduled for 10/30/07 at 6:30 PM.

Karen Talmadge, Ph.D., co-founded and funded Kyphon Inc., and has served as a member of its Board of Directors since the company's inception in 1994. Dr. Talmadge also served as Kyphon's Chief Science Officer since June 2003, and as its Executive Vice Preident since November 1998. In Kyphon's start-up phase from 1994-1994, she was the company's President, Chief Executive Officer and Treasurer. Dr. Talmadge also currently serve on the Board of Directors of two start-up medical device ompanies, Cartilux and VeraLight; the angel investing group, Life Sciences Angels; and the American Diabetes Association. Kyphon was recently acquired by Medtronic for $3.9 billion.

Download flyer [here].


Freshmen Social


Where: AMR I Multi-Purpose Room
When: 5:30 - 6:30 PM  Wednesday, September 12, 2007
Why:

Medtronic Business Plan Competition - Phase III


Requirements: Business Plan [Due March 8] and Presentation [Due April 5]
Phase III is the final phase of the Medtronic Business Plan Competition. Winners will be chosen based on a business plan [75%] and a presentation [15%].
Please include these sections in your business plan:

Presentation:
Your presentation should be no longer than 10 minutes. To encourage the participation of undergraduates, the presenter(s) must be an undergraduate(s). There are no other specific criteria for the presentation; however you must convince the judges within this span of time that your business plan is well-researched, innovative, feasible, and logically planned.



Business Plan Competition Phase I


Download Business Plan Writing Seminar Slides [ppt]


Freshman Ice Cream Social